Epidermolysis Bullosa Medical Research Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 515,452 | 446,511 | 68,941 | 57.3 | 0% |
| 2012 | 334,895 | 444,849 | −109,954 | 54.4 | 0% |
| 2013 | 634,718 | 486,571 | 148,147 | 53.4 | 0% |
| 2014 | 619,279 | 691,395 | −72,116 | 36.3 | 0% |
| 2015 | 1,856,347 | 897,108 | 959,239 | 40.8 | 0% |
| 2016 | 877,163 | 1,551,688 | −674,525 | 18.4 | 0% |
| 2017 | 3,021,108 | 1,506,574 | 1,514,534 | 31.0 | 0% |
| 2018 | 1,025,388 | 2,438,522 | −1,413,134 | 36.3 | 0% |
| 2019 | 2,502,866 | 2,928,321 | −425,455 | 12.1 | 0% |
| 2020 | 1,472,350 | 1,109,360 | 362,990 | 49.9 | 0% |
| 2021 | 772,726 | 1,497,871 | −725,145 | 31.0 | 0% |
| 2022 | 389,920 | 225,491 | 164,429 | 202.2 | 0% |
| 2023 | 1,354,120 | 345,807 | 1,008,313 | 133.9 | 0% |
In its most recent public year (2023), this organization brought in $1,008,313 more than it spent. Its reserves stood at about 133.9 months of spending, up from 57.3 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Epidermolysis Bullosa Medical Research Foundation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works